Your browser doesn't support javascript.
loading
Novel non-linear models for clinical trial analysis with longitudinal data: A tutorial using SAS for both frequentist and Bayesian methods.
Wang, Guoqiao; Wang, Whedy; Mangal, Brian; Liao, Yijie; Schneider, Lon; Li, Yan; Xiong, Chengjie; McDade, Eric; Kennedy, Richard; Bateman, Randall; Cutter, Gary.
Afiliação
  • Wang G; Department of Neurology, School of Medicine, Washington University, St. Louis, Missouri, USA.
  • Wang W; Division of Biostatistics, School of Medicine, Washington University, St. Louis, Missouri, USA.
  • Mangal B; Tenaya Therapeutics, San Francisco, California, USA.
  • Liao Y; Solara Consulting Corp., North Vancouver, British Columbia, Canada.
  • Schneider L; Neogene Therapeutics, Inc., Santa Monica, California, USA.
  • Li Y; Department of Psychiatry and The Behavioral Sciences, Department of Neurology, Keck School of Medicine, University of Southern California, Los Angeles, California, USA.
  • Xiong C; Department of Neurology, School of Medicine, Washington University, St. Louis, Missouri, USA.
  • McDade E; Division of Biostatistics, School of Medicine, Washington University, St. Louis, Missouri, USA.
  • Kennedy R; Department of Neurology, School of Medicine, Washington University, St. Louis, Missouri, USA.
  • Bateman R; Division of Gerontology, Geriatrics, and Palliative Care, Department of Medicine, University of Alabama at Birmingham, Birmingham, Alabama, USA.
  • Cutter G; Department of Neurology, School of Medicine, Washington University, St. Louis, Missouri, USA.
Stat Med ; 43(15): 2987-3004, 2024 Jul 10.
Article em En | MEDLINE | ID: mdl-38727205
ABSTRACT
Longitudinal data from clinical trials are commonly analyzed using mixed models for repeated measures (MMRM) when the time variable is categorical or linear mixed-effects models (ie, random effects model) when the time variable is continuous. In these models, statistical inference is typically based on the absolute difference in the adjusted mean change (for categorical time) or the rate of change (for continuous time). Previously, we proposed a novel

approach:

modeling the percentage reduction in disease progression associated with the treatment relative to the placebo decline using proportional models. This concept of proportionality provides an innovative and flexible method for simultaneously modeling different cohorts, multivariate endpoints, and jointly modeling continuous and survival endpoints. Through simulated data, we demonstrate the implementation of these models using SAS procedures in both frequentist and Bayesian approaches. Additionally, we introduce a novel method for implementing MMRM models (ie, analysis of response profile) using the nlmixed procedure.
Assuntos
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Simulação por Computador / Ensaios Clínicos como Assunto / Modelos Estatísticos / Teorema de Bayes Limite: Humans Idioma: En Revista: Stat Med Ano de publicação: 2024 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Simulação por Computador / Ensaios Clínicos como Assunto / Modelos Estatísticos / Teorema de Bayes Limite: Humans Idioma: En Revista: Stat Med Ano de publicação: 2024 Tipo de documento: Article